Canada Markets open in 8 hrs 37 mins

Paratek Pharmaceuticals, Inc. (PRTK)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
4.4700+0.0400 (+0.90%)
At close: 04:00PM EST
4.4700 0.00 (0.00%)
After hours: 05:39PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.47
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 311.2400
52 Week Low 34.0300
50-Day Moving Average 34.6010
200-Day Moving Average 36.0205

Share Statistics

Avg Vol (3 month) 3280.44k
Avg Vol (10 day) 3260.01k
Shares Outstanding 550.19M
Implied Shares Outstanding 6N/A
Float 843.21M
% Held by Insiders 17.73%
% Held by Institutions 151.42%
Shares Short (Dec. 14, 2021) 43.29M
Short Ratio (Dec. 14, 2021) 412.01
Short % of Float (Dec. 14, 2021) 46.77%
Short % of Shares Outstanding (Dec. 14, 2021) 46.56%
Shares Short (prior month Nov. 14, 2021) 43.58M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Oct. 28, 2014
Ex-Dividend Date 4Oct. 30, 2014
Last Split Factor 21:12
Last Split Date 3Oct. 30, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Sep. 29, 2021


Profit Margin -45.32%
Operating Margin (ttm)-27.43%

Management Effectiveness

Return on Assets (ttm)-10.29%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)114.39M
Revenue Per Share (ttm)2.42
Quarterly Revenue Growth (yoy)79.00%
Gross Profit (ttm)14.35M
EBITDA -30.93M
Net Income Avi to Common (ttm)-51.84M
Diluted EPS (ttm)-1.0970
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)111M
Total Cash Per Share (mrq)2.21
Total Debt (mrq)255.26M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)5.25
Book Value Per Share (mrq)-2.10

Cash Flow Statement

Operating Cash Flow (ttm)-52.31M
Levered Free Cash Flow (ttm)-9.08M